Page 5 note on peer reviews for OA008:
"These results have been written up astwo manuscripts and submitted toleading journals for peer review. The firstmanuscript details the outcomes of thePARA_OA_008 Phase 2 trial and thesecond manuscript compares thePARA_OA_008 results to currentlyavailable and pipeline therapies forosteoarthritis. Peer-reviewed publicationsplay a critical role in establishing scientificcredibility, enhancing visibility within themedical community, and providingvalidation of the clinical data underpinning our program"
Ann: Appendix 4D and Half Year Report, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
43.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $170.8M | |||
| Open | High | Low | Value | Volume |
| 43.0¢ | 43.0¢ | 41.5¢ | $141.6K | 337.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9738 | 41.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 43.0¢ | 76716 | 4 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| PAR (ASX) Chart |